ChinaBulls

AusperBio浩博医药

Biotech/Healthcare

AusperBio is a clinical-stage biopharmaceutical company operating in both China and the United States. It develops proprietary first-in-class and best-in-class targeted oligonucleotide therapeutics.

Source: ChinaBulls — chinabulls.com

Last updated 2026-08-28

Funding Rounds

  • Series C
    RaisedFunding amount requires an account.

    Create Account to Unlock Full Data for Free

    SIGN UP

AusperBio Fundraising Info

Company fundraising information requires an account.

AusperBio Investors and Backers

Unlock Full Data for Free

Get access to market data, insights, backers, analytics and funding rounds.

SIGN UP